ClinicalTrials.gov
ClinicalTrials.gov Menu

National Data Bank for Rheumatic Disease Registry Study of Safety in Patients With Rheumatoid Arthritis Treated With Cimzia® or Disease-modifying Antirheumatic Drugs (DMARDs)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01095393
Recruitment Status : Enrolling by invitation
First Posted : March 30, 2010
Last Update Posted : November 17, 2017
Sponsor:
Collaborator:
National Data Bank for Rheumatic Diseases (NDB)
Information provided by (Responsible Party):
UCB Pharma

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Enrolling by invitation
  Actual Primary Completion Date : December 2016
  Estimated Study Completion Date : April 2018